Zacharias Isaac's Form 4/A amendment
AmendedShockwave Medical, Inc.SWAV · filed Mar 21, 2023
- Accession no.
- 0001209191-23-020419
- Filed
- Mar 21, 2023
- Trade date
- Dec 27, 2022
- Filing delay
- 84 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Dec 28, 2022
This filing lists 1 non-derivative transaction. It carries over 2 transactions from the original filing that it did not restate. Open-market sales total $838.4K. It was filed 84 days after the trade.
This amendment restates part of 0001209191-22-062868 (filed Dec 28, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zacharias IsaacCIK 0001768265 | Officer (President, CCO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2022 | Common Stock | SSaleDisposed | −4,000 | $209.59F2 | −$838,360 | 87,021 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-22-062868 (filed Dec 28, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2022 | Common Stock | MOption exerciseAcquired | +4,000 | $4.03 | +$16,120 | 77,021 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2022 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 5,222 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sale transaction reported here was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/25/2022, amended on 5/23/2022.
- F2
All reported securities were sold at a price of $209.59.
Referenced by the price of 1 transaction in Table I.
- F3
Twenty-Five percent of the shares subject to this option vested on 3/1/2019 and the balance of the shares vested in equal monthly installments thereafter for 36 months.
Remarks
The reporting person previously filed a Form 4 that erroneously reported the exercise of a stock option on December 27, 2022. Such exercise never, in fact, took place. This amendment is being filed to correct: (i) in Table II, Column 9, the number of options remaining on the reporting persons stock option as of December 27, 2022; and (ii) in Table I, Column 5, the number of shares of Common Stock the reporting person owned after the execution of the stock sale he completed on December 27, 2022, which sale was previously reported on the Form 4 amended hereby. Additionally, the reporting persons total in Table I, Column 5 has been corrected in this amendment to include 18,000 restricted stock units which were first awarded to the reporting person on February 1, 2021, but were inadvertently omitted from his total in certain prior Form 4 reports.